BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1795560)

  • 21. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
    Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.
    Sonoda K; Kaku T; Kamura T; Nakashima M; Watanabe T; Nakano H
    Clin Cancer Res; 1998 Jun; 4(6):1517-20. PubMed ID: 9626471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Squamous cell carcinoma antigen in patients with cancer of the uterine cervix.
    Fuith LC; Daxenbichler G
    Gynecol Obstet Invest; 1988; 26(1):77-82. PubMed ID: 3169633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Basic evaluation of measurement of the serum level of squamous cell carcinoma-related antigen (SCC) and its value following irradiation of cancer of the uterine cervix].
    Obata Y; Tadokoro M; Kazato S; Nishi H; Ito M; Shibata H; Mizuno K; Kawamura N; Yamaguchi T; Yoshizumi T
    Gan No Rinsho; 1987 Jan; 33(1):60-4. PubMed ID: 3820601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical value of SCC-antigen, a subfraction of tumor antigen TA-4, in the management of cervical cancer].
    Kato H; Tamai K; Magaya T; Nagai M; Noguchi H; Suehiro Y; Torigoe T
    Gan No Rinsho; 1985 May; 31(6 Suppl):594-9. PubMed ID: 4032751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer.
    Abe A; Nakano T; Morita S; Oka K
    Anticancer Res; 1999; 19(1B):829-36. PubMed ID: 10216501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does preoperative serum squamous cell carcinoma antigen level predict occult extracervical disease in patients with stage Ib invasive squamous cell carcinoma of the cervix?
    Patsner B; Orr JW; Allmen T
    Obstet Gynecol; 1989 Nov; 74(5):786-8. PubMed ID: 2812656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA.
    Molina R; Filella X; Augé JM; Bosch E; Torne A; Pahisa J; Lejarcegui JA; Rovirosa A; Mellado B; Ordi J; Biete A
    Anticancer Res; 2005; 25(3A):1765-71. PubMed ID: 16033097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
    Zeng L
    Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The measurement of SCC antigen in squamous cell carcinoma of the lung].
    Masuoka T; Matueda Y; Ookawa H; Watanabe K; Mimoto S
    Gan No Rinsho; 1985 Jul; 31(8):914-8. PubMed ID: 4032769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone.
    Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Chou HH; Lee SP; Lee CC; Tang SG; Hsueh S
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):492-9. PubMed ID: 15925454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
    Dini MM; Jafari K; Faiferman I
    Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
    Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
    Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A; Tana R; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and prognostic value of MG7-Ag in patients with surgically resectable esophageal squamous cell carcinoma.
    Zhao Y; Jiang Y; Wang R; Zheng X; Wang X; Jin B; Lu Y; Qiao T; Hong L; Fan D
    Ann Surg Oncol; 2007 Sep; 14(9):2621-7. PubMed ID: 17570016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
    Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
    Tashiro T; Nagai H; Yamasaki H; Kuroda Y; Goto Y; Goto J; Nasu M
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunofluorescent study of basement membranes in squamous cell carcinoma of the cervix, vagina, and vulva.
    Pertschuk LP; Boyce JG; Urcuyo R
    Obstet Gynecol; 1977 Apr; 49(4):417-20. PubMed ID: 323765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of SCC antigen in patients with advanced cervix cancer treated with radiation].
    Roszak A; Bratos K; Górny A; Mackiewicz A
    Ginekol Pol; 1996 Sep; 67(9):457-9. PubMed ID: 9289466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of squamous cell carcinoma antigen levels in invasive cervical carcinoma.
    Maiman M; Feuer G; Fruchter RG; Shaw N; Boyce J
    Gynecol Oncol; 1989 Sep; 34(3):312-6. PubMed ID: 2767521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.